Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.23 $9.33 Friday, 10th May 2024 ARDX stock ended at $7.77. This is 3.60% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.78% from a day low at $7.60 to a day high of $8.11.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Nov 28, 2016 $15.55 $15.60 $15.20 $15.25 110 845
Nov 25, 2016 $15.50 $15.65 $15.27 $15.50 96 747
Nov 23, 2016 $15.05 $15.55 $14.56 $15.55 162 728
Nov 22, 2016 $15.50 $15.55 $14.90 $15.20 93 131
Nov 21, 2016 $15.65 $15.65 $15.15 $15.40 141 396
Nov 18, 2016 $15.45 $15.55 $14.70 $15.35 167 457
Nov 17, 2016 $15.00 $15.45 $14.85 $15.40 83 158
Nov 16, 2016 $15.15 $15.45 $14.65 $14.90 109 614
Nov 15, 2016 $15.45 $15.55 $14.90 $15.25 333 216
Nov 14, 2016 $16.10 $16.10 $14.85 $15.50 241 675
Nov 11, 2016 $14.60 $16.20 $14.20 $15.95 467 905
Nov 10, 2016 $14.45 $14.90 $13.95 $14.45 522 439
Nov 09, 2016 $13.45 $14.60 $13.45 $14.05 392 662
Nov 08, 2016 $13.05 $13.05 $13.05 $13.05 105 302
Nov 07, 2016 $13.00 $13.18 $12.73 $12.95 109 500
Nov 04, 2016 $12.25 $12.75 $12.15 $12.70 123 400
Nov 03, 2016 $12.10 $12.75 $10.55 $12.35 135 800
Nov 02, 2016 $12.55 $12.80 $11.85 $11.90 80 500
Nov 01, 2016 $12.35 $13.00 $12.35 $12.70 88 300
Oct 31, 2016 $12.65 $12.75 $12.30 $12.30 80 600
Oct 28, 2016 $12.90 $13.20 $12.60 $12.65 66 600
Oct 27, 2016 $13.60 $13.95 $12.95 $13.05 90 800
Oct 26, 2016 $13.70 $14.00 $13.45 $13.45 96 200
Oct 25, 2016 $13.80 $14.00 $13.70 $13.75 98 300
Oct 24, 2016 $13.40 $14.15 $13.26 $13.90 146 200
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT